MATERIAL SAFETY DATA SHEET
-----------------------------------------------------------------------------------------------------------------------------
--
Vet-A-Mix, P.O. Box 130, Shenandoah, IA 51601-0130
A Division of LLOYD, Inc. Pipa-Tabs 50 mg and 250 mg
Phone No. (712) 246-4000 MSDS Date: 2/16/93 (Original)
Page 1 of 2 12/19/95; 6/28/06 (Revised)
Product Name: Pipa-Tabs 50 mg and 250 mg
1. INGREDIENTS: (% w/w), unless otherwise noted
EXPOSURE LIMITS, ppm
OSHA ACGIH
TLV (mg/m3)
COMPONENT CAS# % PEL
Piperazine Dihydrochloride 142-64-3 81.4 5
Dicalcium Phosphate 7757-93-9 7.0 --None Established--
This document is prepared pursuant to the OSHA Hazard Communication Standard (29 CFR 1910.1200).
Only those ingredients composing >1% (>0.1% for carcinogens or suspect carcinogens) of the formula
(w/w) and which have hazards identified are listed.
2. PHYSICAL DATA:
APPEARANCE: Blue tablets; 50 mg tablet is round; 250 mg tablet is elliptical. Other physical data have
not been determined.
3. FIRE AND EXPLOSION HAZARD DATA:
This has not been evaluated. Thermal decomposition of the piperazine dihydrochloride may yield
hydrogen chloride and oxides of carbon and nitrogen. Avoid breathing noxious fumes.
EXTINGUISHING MEDIA: Water fog, alcohol foam, CO2, dry chemical.
4. REACTIVITY DATA:
This has not been evaluated. The product is expected to be stable under normal storage conditions;
avoid strong oxidizers.
5. ENVIRONMENTAL AND DISPOSAL INFORMATION:
ACTION TO TAKE FOR SPILLS/LEAKS: Sweep up and dispose of in DOT-approved waste containers.
Keep out of sewers, storm drains, surface waters and soil.
DISPOSAL METHOD: Dispose of contaminated product and materials used in cleaning up spills or leaks
in a manner approved for this material. Consult appropriate federal, state and local regulatory agencies
to ascertain proper disposal procedures.
6. HEALTH HAZARD DATA:
EYE: This product may cause transient minor irritation if eye contact occurs. It is not expected to irritate
the eyes under normal conditions of use.
SKIN CONTACT: This product is not expected to irritate the skin under normal conditions. Piperazine
dihydrochloride is minimally irritating.
INGESTION: This has not been evaluated. Piperazine dihydrochloride is believed to be of low toxicity.
INHALATION: Inhalation exposure under normal conditions of use is not likely to cause adverse effects,
however irritation may occur if use conditions generate dust.
MATERIAL SAFETY DATA SHEET
-----------------------------------------------------------------------------------------------------------------------------
--
Vet-A-Mix, P.O. Box 130, Shenandoah, IA 51601-0130
A Division of LLOYD, Inc. Pipa-Tabs 50 mg and 250 mg
Phone No. (712) 246-4000 MSDS Date: 2/16/93 (Original)
Page 2 of 2 12/19/95; 6/28/06 (Revised)
Piperazine Dihydrochloride--Oral LD50 (rat): >5,000 mg/kg
Dicalcium Phosphate--Oral LD50 (rat): 10,000 mg/kg; Dermal LD50 (rabbit): >7940 mg/kg
7. FIRST AID:
EYES: Immediately flush eyes with copious amounts of running water for 15 minutes.
SKIN: Wash with soap and water.
INGESTION: SEEK MEDICAL ATTENTION IMMEDIATELY. Treatment is by gastric lavage or emesis.
INHALATION: If a person has been exposed to excessive quantities of dust due to mishaps, move the
person to fresh air. Give artificial respiration if not breathing.
Seek medical attention immediately if excessive exposure occurs.
8. HANDLING PRECAUTIONS:
There is no OSHA PEL or ACGIH TLV for this product. Under normal conditions of use, no special
handling precautions are required in areas with adequate ventilation. However, under conditions of
prolonged exposure in which quantities of dust are generated, mechanical ventilation, safety glasses with
side shields, gloves and a NIOSH approved dust respirator are recommended.
SPECIAL PRECAUTIONS TO BE TAKEN IN HANDLING AND STORAGE: Exercise reasonable care
and caution.
REGULATORY INFORMATION: (Not meant to be all-inclusive--selected regulations represented.)
NOTICE: The information herein is presented in good faith and believed to be accurate as of the effective date
shown above. However, no warranty, express or implied, is given. Regulatory requirements are subject to
change and may differ from one location to another; it is the buyer's responsibility to ensure that its activities
comply with federal, state or provincial, and local laws. The following specific information is made for the purpose
of complying with numerous federal, state or provincial, and local laws and regulations. See MSDS for health and
safety information.
U.S. REGULATIONS: SARA HAZARD CATEGORY: This product has been reviewed according to the
federal EPA "Hazard Categories" promulgated under Sections 311 and 312 of the Superfund Amendment and
Reauthorization Act of 1986 (SARA Title III) and is considered, under applicable definitions, to be exempt from
reporting requirements. Nevertheless, potential reporters should check with their state emergency response
commissions to determine if this product must be reported under applicable state requirements.
Dicalcium phosphate contains the following chemicals considered by the State of California's Safe Drinking Water
and Toxic Enforcement Act of 1986 (Proposition 65) as causing cancer or reproductive toxicity and for which
warnings are now required: Arsenic--CAS No. 7440-38-2; Cadmium--CAS No. 7440-43-9;
Lead--CAS No. 7439-92-1.
|